Value of new business +17% to £401M, boosted by the U.K., France and Asia, although sales slumped in Italy and Spain.
Underlying pretax profit £605M vs £309M.
IFRS profit after tax £776M vs loss of £624M a year earlier, when Aviva took a £3.3B writedown on U.S. operations.
Operational capital generation £936M vs 906M last year.
Combined operating ratio, or claims and expenses as a proportion of premiums, +96.2% vs 95.5% last year, indicating that underwriting didn't improve.
Restructuring costs -10% to £164M.
Expects to complete the sale of its U.S. operations by the end of 2013.
As expected, to pay H1 dividend of 5.6 pence/share.
Shares +6.3% in London.